Medicare will start the GLP-1 Bridge program July 1. Older adults who qualify for the weight-loss drugs will pay a monthly $50 copay.

Orforglipron is the active ingredient in Foundayo, the weight management pill approved in April 2026 by the U.S. Food and Drug Administration (FDA) for adults with obesity or overweight with weight-related medical problems.

For years, GLP-1 medication has transformed conversations around weight loss but left many virtually locked out by costs. Now, that's changing.

As a new weight-loss pill and high-dose injection enter the market, costs have plummeted to a fraction of their original price GLP-1 drugs now come in injectables and pills - but figuring out how to pay for them can get complicated. Taking GLP-1s once ...

Whether you’re on a weight loss journey of your own or not, you probably haven’t been able to avoid hearing about the sudden popularity of medications like Ozempic — a diabetes drug that had major shortages when doctors discovered that it could be ...